Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey

Background and Aim:Quadruple therapy plays a key role in heart failure (HF) management and the latest recommendation is “four pillar drugs on board in 4 weeks.” At present, there is no fixed-dose combination (FDC) of these foundational therapies existing in India. The present study aimed to understa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kamal Sharma, Ajay Pandey, Prafulla Kerkar, Sameer Shrivastava, Satyanarayan Routray, Smit Shrivastava, Aziz Khan, Preethi Naik, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Akhil Sharma, Johann Christopher, Rohith Reddy
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2025-01-01
Serie:	Journal of the Practice of Cardiovascular Sciences
Soggetti:	arni beta-blockers heart failure quadruple therapy sodium-glucose cotransporter 2 inhibitors
Accesso online:	https://journals.lww.com/10.4103/jpcs.jpcs_46_24
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!